IFNA1 and cryohydrocytosis: Until the recent introduction of direct antiviral drugs for the treatment of CHC, recombinant pegylated IFN‐alpha 2 (pegIFN‐α) had been an essential component of the standard of care for CHC for over 25 years, and it is still used in many parts of the world.